[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100568338":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":20,"locations":29,"responsibleParty":59,"collaborators":19,"id":62,"slug":19,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":63,"sex":69,"minAge":70,"maxAge":19,"enrollmentInfo":71,"targetDuration":19,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":50,"whyStopped":19,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":94},{"fullName":5,"class":6},"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Optical coherence tomography measurements during transurethral resection of a bladder tumour","Single arm",[12],"Device: Optical coherence tomography",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DEVICE","Optical coherence tomography","Measurement with opctical coherence tomography of tumour and normal bladder tissue during transurethral resection of a bladder tumour (TURBT)",[9],null,[21,26],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Marinka Remmelink, MD","CONTACT","+310204441376","m.j.remmelink@amsterdamumc.nl",{"name":27,"role":23,"phone":19,"phoneExt":19,"email":28},"Jorg R Oddens, MD, PhD","j.r.oddens@amsterdamumc.nl",[30,49],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Amsterdam University Medical Center","NOT_YET_RECRUITING","Amsterdam","North Holland","1081HV","Netherlands","NL",{"type":39,"coordinates":40},"Point",[41,42],4.88969,52.37403,{"lat":42,"lon":41},[45,47],{"name":22,"role":23,"phone":46,"phoneExt":19,"email":25},"00310204441376",{"name":27,"role":48,"phone":19,"phoneExt":19,"email":19},"PRINCIPAL_INVESTIGATOR",{"facility":31,"status":50,"city":33,"state":19,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":51,"geoPoint":53,"contacts":54},"RECRUITING",{"type":39,"coordinates":52},[41,42],{"lat":42,"lon":41},[55,58],{"name":56,"role":23,"phone":57,"phoneExt":19,"email":25},"Marinka J Remmelink, MD","0031204441376",{"name":27,"role":48,"phone":19,"phoneExt":19,"email":19},{"type":48,"investigatorFullName":60,"investigatorTitle":61,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"Harrie P. Beerlage","Prof. dr. H.P. Beerlage","100568338",false,"NCT06679920","Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment","IDEAL Phase II Study of a Newly Designed Optical Coherence Tomography Probe During Transurethral Resection for Optimizing Bladder Cancer Diagnosis and Treatment","BLOCT","Inclusion Criteria:\n\n* Age \\> 18 years.\n* Have at least 1 suspected bladder tumour seen at cystoscopy.\n* Have a bladder that is accessible for cystoscopy.\n* Be in a physical condition to undergo a TURBT.\n* Eligible patients must be fully informed about the study and written signed informed consent must be obtained prior to any study related investigation\u002Fintervention.\n\nExclusion Criteria:\n\n* Pregnant or lactating women.\n* The only tumour site is at the bladder neck.\n* The tumour(s) is larger than 2 centimetres in diameter.\n* \\>5 tumours present.\n* Solely a suspected flat lesion present.","ALL","18 Years",{"count":72,"type":73},15,"ESTIMATED","INTERVENTIONAL",[76],"NA","The goal of this clinical trial is to see if a new designed optical coherence tomography catheter can be used in bladder cancer in patients undergoing a transurethral resection of a bladder tumour. The main question it aims to answer is:\n\n\\- Is the optical coherence tomography catheter feasible in capturing images of bladder tumours and normal bladder wall during a transurethral resection of a bladder tumour?\n\nParticipants will undergo measurements with a new optical coherence tomography device during the transurethral resection of their bladder tumour(s).",[79],"Bladder Cancer",[81,82,83],"OCT","Optical Coherence Tomography","Bladder cancer","2024-12-04",{"date":86,"type":87},"2024-12-06","ACTUAL",{"date":89,"type":73},"2024-12",{"date":91,"type":73},"2025-04",{"name":93,"class":6},"Amsterdam UMC",2]